Fosun Pharmaceutical: Fosun Pharmaceutical Industry plans to invest 550 million yuan to subscribe for 6.5315 million shares of newly added Fosun Antechgene stock.

Fosun Pharma announced that its holding subsidiary, Fosun Pharma Anticancer, plans to issue a total of 11.4954 million shares to 4 investors at a price of 84.21 yuan per share. Among them, external investors plan to subscribe for a total of 418 million yuan to subscribe for a total of 4.9639 million shares, while the holding subsidiary of the company, Fosun Pharma Industry, plans to subscribe for 550 million yuan to subscribe for 6.5315 million shares.